Meditope Biosciences Lands $1,624,080 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8eb725af-5ffc-4623-a08f-7385955d54ad
Date
10/9/2015
Company Name
Meditope Biosciences
Mailing Address
301 North Lake Avenue Pasadena, CA 91101 USA
Company Description
Discovered at City of Hope, Meditope’s technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific Lego-like system that is able to attach and detach drugs to antibodies without the need for chemical conjugation.
Website
http://www.meditope.com
Transaction Type
Venture Equity
Transaction Amount
$1,624,080
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed